LOS ANGELES, November 22, 2017 /PRNewswire/ —
The world’s largest cannabis producers are all in a mad rush to cover the most ground, and produce the most organic product. If numbers from the recent Marijuana Business Factbook 2017 are correct, the US legal cannabis industry is expected to grow 30% in 2017, 45% in 2018, and 300% over the 5-year span of 2016-2021.
Therefore it’s no wonder that this blossoming industry has so far already generated its own multi-billion dollar majors, such as Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF) and GW Pharmaceuticals plc – both with market caps closing in on US$3 billion.
Not far behind are Aurora Cannabis (TSX: ACB) (OTC: ACBFF) whose valuation is nearing US$2 billion, and the newly-minted billion-dollar corporations of Aphria Inc. (TSX: APH) (OTC: APHQF) and MedReleaf Corp.
As investment dollars continue to flood into the sector, legal cannabis growers are investing heavily into real estate for their growing operations.
Investors who may have missed out on the ground floor for the big boys, such as Canopy and Aurora aren’t being left in the cold, however. One of the most aggressive newcomers to the grower space is MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF), that is very much keeping up with the Joneses in terms of square footage, and breaking ground for its soon-to-be-massive facilities in Canada and Australia.
While legalized states in the US struggle with their federal regulatory counterparts in Washington DC, fellow developed-world populations in Canada and Australia are continuing to give investors much to smile about, in terms of potential for this market still in its infancy.
As the countdown towards full recreational legalization in Canada gets nearer, the prospect of an onslaught of demand has sent shares soaring not only for MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF), but for other Canadian growers Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF), Aurora Cannabis (TSX: ACB) (OTC: ACBFF), Aphria Inc. (TSX: APH) (OTC: APHQF), and MedReleaf Corp. as well.
BIGGER, BETTER GREENHOUSES
The race to be the biggest and best cannabis grower has been making headlines, as the world’s first mega-greenhouses space began breaking ground, and coming closer to reality this year.
Gone were the days of greenhouses with less than 100,000 square feet in production facility space. Now, the new normal is apparently going to be hundreds of thousands, to over a million square feet reserved for greenhouse growth.
At first it was Aurora Cannabis turning heads with its $100 million Aurora Sky project, at the Edmonton International Airport. Construction commenced on the enormous 800,000 square foot cannabis production facility in July of this year, with completion scheduled for the first half of 2018.
Not to be outdone, industry front-runner Canopy Growth announced it would develop up to 3 million square feet of additional greenhouse capacity in British Columbia. The deal would see Canopy strike a deal with an already established private greenhouse partner, to convert a 1.3 million square foot facility from its current crop of peppers, to cannabis plants-all with the intention of commercial production being ready in time for the July 1, 2018 legalization kickoff date.
But as both those multi-billion-dollar companies have made headlines, up-and-comer MYM Nutraceuticals has successfully commissioned a massive undertaking of its own.
Through a joint effort with the City of Weedon, Quebec, MYM’s massive Weedon Project is destined to the largest cannabis cultivation site in the country.
With the approval and contribution of 329 acres of land from the City of Weedon, MYM will build a 1.5 million square foot greenhouse facility, estimated to produce sales of $750 million by 2021, with profit estimates of $325 million.
Attached to the facility will be an education centre, working in congruence with universities regarding botany degrees, vocational programs with certifications specializing in the cannabis plant and operations from seed to sale. In essence, this massive project is designed to turn Weedon into the undisputed cannabis capital of Canada.
MYM‘S AUSSIE ADVANTAGE
While waves were made by MYM recently not only with an update on its Weedon Project, and with its sister facility in Laval, Quebec, but also with its expansionary efforts on the other side of the planet.
The market truly began to take notice, as MYM announced recently an expansion on its plans to build a facility in New South Wales, Australia. The expansion would make bring the new size of the project to a total of 1.2 million square feet of greenhouse and extraction facilities, bringing MYM’s global square footage very close to Canopy’s explosive 3 million square foot earmark in British Columbia.
The announcement caused MYM’s second significant share price boost in just one week.
“Demand for cannabis is growing worldwide and with MYM actively investigating all opportunities in each sector of the cannabis industry, it will develop MYM into a complete Global seed to sale company,” said Rob Gietl, Chief Executive Officer of MYM Nutraceuticals.
“MYM is working to open up cannabis distribution channels globally to accelerate our growth. Our Weedon project alone has 329 acres to expand production on. As recreational cannabis opens in more markets and as global markets expand, we plan on being ahead of the curve and have supply chains ready.”
Australia is positioning itself as a market to be the next Canada.
As the country has continuously introduced more and more progressive medical cannabis laws over the last few years, it’s safe to assume that legal recreational sales will be soon around the corner.
With a population of more than 24 million people, Australia’s cannabis market has been estimated to grow to roughly CAD $9 billion over the next seven years, making the down-under nation a very attractive market for producers.
Having a leg up on the competition and being one of the first large-scale producers in the Australian market should give MYM a significant first-mover advantage over the competition.
Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF)
Formerly known as Tweed Marijuana Inc., Canopy Growth is a multi-licensed, geographically diverse marijuana producer, described as “one of the world’s – and Canada’s first – premier exporters of marijuana” by the Financial Post in 2016. Canopy is the parent company of licensed cannabis producers, Tweed Inc., Tweed Farms Inc., Bedrocan Canada Inc., as well as newly acquired Mettrum Health Corp. Canopy currently has a combined growing platform of over 665,000 sq. ft. of production space. It was also the first federally regulated, publicly traded cannabis producer in North America, and the first billion-dollar cannabis corporation. Canopy Growth was founded in 2014, and is based in Smith Falls, Ontario.
Aurora Cannabis (TSX: ACB) (OTC: ACBFF)
Aurora Cannabis boasts the second highest square footage approved for cannabis production in Canada. Together with its subsidiaries, Aurora produces and distributes medical marijuana products in Canada. The company’s products consist of dried cannabis and cannabis oil.
Aurora is the only cannabis producer located in the province of Alberta, giving the company a cost advantage through its free use of fresh mountain-fed water used on site, and housed under the lowest corporate tax rates and power rates in Canada. Capitalizing on numerous farm credit programs provided by the province, Aurora has positioned itself as arguably the lowest cost-per-gram licensed producer in Canada. Aurora became a licensed producer in 2015, and is based in Edmonton, Alberta.
Aphria Inc. (TSX: APH) (OTC: APHQF)
Aphria is one of Canada’s lowest cost licensed cannabis producers, specializing in the production, suppy, and sale of medical cannabis. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders. The company sells its products through its online store or phones, as well as engages in the wholesale shipping of medical marijuana plant cuttings and dried buds to other licensed producers. Aphria Inc. is headquartered in Leamington, Canada.
For a more in-depth look into MYM Nutraceuticals you can view the in-depth report at American News Group: http://usanewsgroup.com/2017/11/19/do-cannabis-stocks-offer-this-decades-best-opportunity-2/
USA News Group
Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of USA News Group only and are subject to change without notice. USA News Group assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.
DISCLAIMER: USA News Group is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with USA News Group or any company mentioned herein. The commentary, views and opinions expressed in this release by USA News Group are solely those of USA News Group and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact Information:
FN Media Group, LLC
Media Contact e-mail: email@example.com
U.S. Phone: +1-(954)-345-0611
SOURCE USA News Group